PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Liz Kane
Impactful Strategy

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs